RecruitingNCT05598983

Non-contact Proactive Remote Monitoring of COPD Exacerbations

Non-contact Proactive Remote Monitoring to Facilitate Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)


Sponsor

Life Detection Technologies

Enrollment

75 participants

Start Date

May 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are: * Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT? Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study monitors people with COPD (chronic obstructive pulmonary disease, a lung condition that makes breathing difficult) remotely using sensors and devices, without requiring them to come into a clinic. The goal is to detect worsening episodes (called exacerbations) earlier so they can be treated sooner. **You may be eligible if...** - You have a confirmed diagnosis of COPD - You have had at least one worsening episode (exacerbation) in the past year - You are over 18 years old - You are willing to use monitoring devices and fill out questionnaires - You speak adequate English **You may NOT be eligible if...** - You are pregnant - Your BMI is greater than 45 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Royal Free Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05598983


Related Trials